tiprankstipranks
Inmune Bio Completes Phase 2 Trial for CORDStrom
PremiumCompany AnnouncementsInmune Bio Completes Phase 2 Trial for CORDStrom
12d ago
INmune Bio announces plans to submit FDA BLA for CORDStrom
Premium
The Fly
INmune Bio announces plans to submit FDA BLA for CORDStrom
12d ago
INmune Bio expands INKmune trial in prostate cancer to veterans
Premium
The Fly
INmune Bio expands INKmune trial in prostate cancer to veterans
25d ago
INmune Bio, OmniScience announce partnership to accelerate Alzheimer’s trial
PremiumThe FlyINmune Bio, OmniScience announce partnership to accelerate Alzheimer’s trial
3M ago
INmune Bio, OmniScience partner to accelerate trial with Vivo
Premium
The Fly
INmune Bio, OmniScience partner to accelerate trial with Vivo
3M ago
INmune Bio announces enrollment of 208 patients in Phase 2 trial of early AD
Premium
The Fly
INmune Bio announces enrollment of 208 patients in Phase 2 trial of early AD
3M ago
INmune Bio to host webinar on cognitive testing using EMACC, CDR-SB
PremiumThe FlyINmune Bio to host webinar on cognitive testing using EMACC, CDR-SB
4M ago
INmune Bio announces publication of XPro1595 data in Cell Reports
Premium
The Fly
INmune Bio announces publication of XPro1595 data in Cell Reports
4M ago
INmune Bio initiated with a Buy at Alliance Global Partners
Premium
The Fly
INmune Bio initiated with a Buy at Alliance Global Partners
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100